Elon Musk’s Neuralink gets FDA approval for 2nd patient

The U.S. Food and Drug Administration (FDA) has granted Neuralink, Elon Musk’s brain-machine interface company, approval to implant its brain chip in a second human subject. This decision follows adjustments made to address issues encountered with the first participant, Noland Arbaugh, who shared his transformative yet challenging experience with the device. Noland Arbaugh, a quadriplegic, … Continue reading Elon Musk’s Neuralink gets FDA approval for 2nd patient